Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 4 (2007), Issue 6 (June)

1. Cladribine in aggressive forms of multiple sclerosis.
   Eur J Neurol, 14(6): 686-9. [Abstract] [Full-text]
2. Disparities in the management of multiple sclerosis-related bladder symptoms.
   Neurology, 68(23): 1971-8. [Abstract] [Full-text]
3. Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.
   BMC Genet, 8: 25. [Abstract] [Full-text]
4. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
   J Neurol Sci, 258(1): 52-9. [Abstract] [Full-text]
5. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
   J Neurol Sci, 258(1): 69-74. [Abstract] [Full-text]
6. Neutralizing antibodies to interferon.
   Neurology, 68(24): S16-22. [Abstract] [Full-text]
7. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
   Neurology, 68(24): S12-5. [Abstract] [Full-text]
8. Predicting short-term disability in multiple sclerosis.
   Neurology, 68(24): 2059-65. [Abstract] [Full-text]
9. Regional variations in the prevalence of multiple sclerosis in French farmers.
   J Neurol Neurosurg Psychiatry, 78(7): 707-9. [Abstract] [Full-text]
10. Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.
    J Neurol Neurosurg Psychiatry, 78(7): 757-9. [Abstract] [Full-text]
11. Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis.
    Clin J Pain, 23(6): 473-81. [Abstract] [Full-text]
12. Natural history of multiple sclerosis with childhood onset.
    N Engl J Med, 356(25): 2603-13. [Abstract] [Full-text]

© 2004-2008 Multiple Sclerosis Research Today. All Rights Reserved.